The percentage of APRIL-expressing B cells, AMs and AECs is higher in the lungs of patients with both COPD and NSCLC than in patients with COPD or NSCLC alone or control subjects. The gene discussed is TNFSF13; the disease is non-small cell lung carcinoma.